Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04177394 · ClinicalTrials.gov registry record
MitraClip EXPAND G4 Study
A clinical trial of Mitral Regurgitation and Mitral Valve Regurgitation, sponsored by Abbott Medical Devices.
- Active
- Registry status
- 1,164
- Enrollment target
- 20
- Study locations
NCT04177394 is a study of Mitral Regurgitation and Mitral Valve Regurgitation that is active but no longer recruiting, run by Abbott Medical Devices. The registered enrollment target is 1,164 participants, above the 979-participant average among 26 other Mitral Regurgitation trials with a reported enrollment target (19% higher). The trial reports 20 study locations across 13 states.
The verdict
NCT04177394, a study of Mitral Regurgitation and Mitral Valve Regurgitation, is active but no longer recruiting, sponsored by Abbott Medical Devices.
- ACTIVE NOT RECRUITING
- Registry status
- 1,164 participants
- Enrollment target
- 20
- Study locations
Study Summary
This primary objective of the EXPAND G4 study is to confirm the safety and performance of the MitraClip G4 System in a post-market setting.
Conditions Studied
Interventions
- DEVICE MitraClip G4 System
Study Locations (20)
New York
- Albany Medical Center - Albany
- NYU Langone Health - New York
- Mount Sinai Hospital - New York
- Hudson Valley Cardiovascular Practice, P.C. - Poughkeepsie
California
- Scripps Health - La Jolla
- University of California - Davis Medical Center - Sacramento
- Los Robles Regional Medical Center - Thousand Oaks
Alabama
- University of Alabama at Birmingham - Birmingham
- Cardiology Associates of Mobile, Inc. - Mobile
Illinois
- Northshore University Health System - Evanston
- Prairie Education & Research - Springfield
Arkansas
- Arkansas Heart Hospital - Little Rock
Connecticut
- Cardiology Associates of Fairfield County, PC - Norwalk
Florida
- NCH Healthcare System - Naples
Kansas
- Via Christi - Wichita
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,164 participants |
| Start Date | 2020-01-17 |
| Est. Completion | 2028-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04177394
The ClinicalTrials.gov registry entry for NCT04177394 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,164 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 979-participant average among 26 other Mitral Regurgitation trials with a reported enrollment target (19% higher). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Mitral Regurgitation appearing as the primary indexed condition, and to 1 intervention - of which MitraClip G4 System is the first listed.
NCT04177394 reports 20 study locations spanning 13 distinct geographic areas - top geographies include New York, California, Alabama.
Frequently Asked Questions
What is clinical trial NCT04177394 about?
NCT04177394 is a clinical study titled "MitraClip EXPAND G4 Study". This primary objective of the EXPAND G4 study is to confirm the safety and performance of the MitraClip G4 System in a post-market setting.
What is the current status of trial NCT04177394?
This trial is currently active not recruiting. The enrollment target is 1,164 participants. The study started on 2020-01-17. Estimated completion is 2028-03.
What conditions does trial NCT04177394 study?
This clinical trial studies the following conditions: Mitral Regurgitation, Mitral Valve Regurgitation.
What interventions are being tested in trial NCT04177394?
The interventions under investigation include: MitraClip G4 System (DEVICE).
Who is sponsoring clinical trial NCT04177394?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04177394 being conducted?
This trial has 20 study locations across Alabama, Arkansas, California, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mitral Regurgitation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
An Early Feasibility Study of the HighLife 28mm Trans-Septal Transcatheter Mitral Valve Replacement System
RECRUITING · NA
-
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
RECRUITING · NA
-
EFS of the CardioMech MVRS
RECRUITING · NA
-
Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study
RECRUITING
-
Novel Characterization of Sex Specific Biologic Signatures in Valvular Heart Disease
RECRUITING
-
In Search of Best Practices for Patients With Heart Failure and Secondary Mitral Regurgitation: An Evaluation of the Inova Heart Failure Treatment Algorithm
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.